ExScale Biospecimen Solutions Company
%20.jpg)
ExScale Biospecimen Solutions provide the market with process knowledge and unique chemical technology for large-scale, uncomplicated preparation of DNA and/or RNA. ExScale introduces automated, next-generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded (FFPE) tissue sections using paramagnetic beads. The technology enables serial extraction of DNA and RNA from the same biospecimen where the isolated nucleic acids are of optimal quality for next-generation sequencing and other downstream applications.
Founded Date:
2012-01-01
Last Funding Type:
Pre-Seed
Headquarters:
Uppsala, Uppsala Lan, Sweden
Investors Number:
1
Technology:
P4 Medicine
Employee Number:
1-10
Industry:
Health Care, Science and Engineering
Estimated Revenue:
$1M to $10M
Funding Status:
Seed
Investor Type:
For Profit